Reddy, D., Peters, M., Shah, T., van Son, M., Bertoncelli, M. T., Huber, P., Lomas, D., Rakauskas, A., Miah, S., Eldred-Evans, D., Guillaumier, S., Hosking-Jervis, F., Engle, R., Dudderidge, T., Hindley, R., Emara, A., Nigam, R., McCartan, N., Valerio, M., Afzal, N., Lewi, H., Orczyk, C., Ogden, C., Shergill, I., Persad, R., Virdi, J., McCracken, S., Greene, D., Moore, C., Arya, M., Winkler, M., Emberton, M., & Ahmed, H. (n.d.). mP55-06 FOCAL ABLATIVE SALVAGE THERAPY FOR RADIO-RECURRENT PROSTATE CANCER: 6 YEAR ONCOLOGICAL AND SAFETY OUTCOMES. Journal of urology, 207, e938–. http://access.bl.uk/ark:/81055/vdc_100153741342.0x000030